company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36400000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33298000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1309000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71007000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,654000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,623000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,,totalassets,Total Assets,=,debit,usd,72284000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,205000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5600000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9234000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,43714000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,383000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,44097000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53331000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,356770000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-337823000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,18953000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,18953000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,18953000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,,2011-06-30,2011-08-08 16:22:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,72284000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33873000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,29962000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,897000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64732000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,546000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,614000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,,totalassets,Total Assets,=,debit,usd,65892000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3524000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6953000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,42857000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,323000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,43180000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,50133000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,358160000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-342403000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,15759000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,15759000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,15759000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,,2011-09-30,2011-11-08 16:15:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,65892000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,73445000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,65134000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1287000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,139866000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,319000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,542000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,542000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,,totalassets,Total Assets,=,debit,usd,140727000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8431000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,41143000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,215000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41358000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49789000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,448072000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-357124000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,90938000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,90938000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,90938000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,,2012-03-31,2012-05-10 06:13:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,140727000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67366000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,58831000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2326000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,128523000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,242000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,,totalassets,Total Assets,=,debit,usd,128942000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8414000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11843000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,40286000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,178000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40464000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52307000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,450430000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-373785000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,76635000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,76635000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,76635000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,,2012-06-30,2012-08-09 08:03:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,128942000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56057000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,52227000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1507000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,109791000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,166000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,,totalassets,Total Assets,=,debit,usd,110134000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17775000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21204000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,39429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,140000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,39569000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60773000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,453695000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-404349000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49361000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49361000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49361000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,,2012-09-30,2012-11-08 19:58:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,110134000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67054000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,47502000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1998000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,116554000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,,totalassets,Total Assets,=,debit,usd,116738000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6671000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10312000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20412000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37714000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37714000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,58126000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,514771000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-456172000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,13000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,58612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,58612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,58612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,,2013-03-31,2013-05-09 14:16:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,116738000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55813000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,40178000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2985000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,98976000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,,totalassets,Total Assets,=,debit,usd,99157000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7842000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7326000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18597000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36857000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36857000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,55454000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,518122000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-474418000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,43703000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,43703000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,43703000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,,2013-06-30,2013-08-06 21:28:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,99157000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48730000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34085000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1790000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,84605000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,120000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,812000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,989000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,,totalassets,Total Assets,=,debit,usd,85714000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9227000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8235000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20891000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,89000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36089000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56980000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,521713000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-492990000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,11000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,28734000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,28734000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,28734000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,,2013-09-30,2013-11-12 13:55:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85714000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37563000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117528000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1289000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,156380000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,650000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,903000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1080000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,,totalassets,Total Assets,=,debit,usd,158110000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5442000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12793000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21664000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,80973000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34286000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,337000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115596000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,137260000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,560217000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-539373000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20850000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20850000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20850000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,,2014-03-31,2014-05-09 16:09:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158110000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31107000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,102194000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5840000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,139141000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,675000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,884000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1061000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,,totalassets,Total Assets,=,debit,usd,140877000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8071000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13072000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24572000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,81928000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,33429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,401000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115758000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,140330000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,564415000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-563880000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,12000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,,2014-06-30,2014-08-08 17:13:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,140877000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,68358000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,50277000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,32014000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,754000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1757000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,153160000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,718000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,426000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,603000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,,totalassets,Total Assets,=,debit,usd,154481000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4743000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13563000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21735000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,82911000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,32572000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,378000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115861000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,137596000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,569480000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-552607000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,12000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,16885000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,16885000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,16885000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,,2014-09-30,2014-11-10 13:47:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,154481000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75075000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,113570000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4530000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1356000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1277000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,196355000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,817000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,789000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,,totalassets,Total Assets,=,debit,usd,197961000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2460000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15180000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8229000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25869000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,84933000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,74057000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,305000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,159842000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,185711000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,581466000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-569232000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,,2015-03-31,2015-05-08 12:11:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,197961000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,71585000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,103475000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6804000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4909000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2026000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,189346000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,765000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,882000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,177000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1059000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,,totalassets,Total Assets,=,debit,usd,191170000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6593000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21795000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8229000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36617000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,85973000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,72000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,258000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,158778000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,195395000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,587502000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-591737000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-4225000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-4225000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-4225000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,,2015-06-30,2015-08-07 17:13:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,191170000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,154267000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,79175000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4560000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11068000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2231000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,251848000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,931000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1415000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,138000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1553000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,,totalassets,Total Assets,=,debit,usd,254332000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3917000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21526000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10004000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,35447000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,87043000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,84849000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,547000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,206000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,172645000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,208092000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,650757000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-602878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1639000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46240000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46240000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46240000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,,2015-09-30,2015-11-06 21:04:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,254332000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67967000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,115000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,59129000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2789000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,15002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2559000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,262446000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1434000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,60945000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,50139000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,111084000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,,totalassets,Total Assets,=,debit,usd,374964000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4552000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16215000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9637000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30404000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,88998000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,80245000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,164439000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,333682000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,364086000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,656679000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-643035000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2766000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,10878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,10878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,10878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,,2016-03-31,2016-05-05 16:27:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,374964000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,78173000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,165203000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,20983000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2922000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11458000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3965000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,282704000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1377000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61210000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,138000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,61348000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,,totalassets,Total Assets,=,debit,usd,345429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4105000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21067000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9600000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34772000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,90142000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,77737000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,152780000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,320659000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,355431000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,659144000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-668265000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-881000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-10002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-10002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-10002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,,2016-06-30,2016-08-05 14:20:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,345429000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,74427000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,165082000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1495000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2098000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,23999000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6080000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,273181000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1260000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,78032000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3152000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,188000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,81372000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,,totalassets,Total Assets,=,debit,usd,355813000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13500000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11970000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37747000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2256000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,65473000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,91319000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6361000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,119243000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,216923000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,282396000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,695774000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-620602000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1755000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73417000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73417000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73417000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,,2016-09-30,2016-11-04 21:42:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,355813000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,76656000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,40000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9985000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6277000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,20663000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4938000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,158519000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,927000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,74077000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2672000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,188000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,76937000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,,totalassets,Total Assets,=,debit,usd,236383000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15640000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32106000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1713000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49459000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24701000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6069000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,164009000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,194779000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,244238000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,703948000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-714298000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2495000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-7855000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-7855000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-7855000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,,2017-03-31,2017-05-11 18:10:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,236383000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36665000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49953000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7636000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,15753000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4323000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114330000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,814000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,72093000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2574000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,188000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,74855000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,,totalassets,Total Assets,=,debit,usd,189999000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8277000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30604000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2923000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,41804000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25029000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6453000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,158743000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,190225000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,232029000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,706822000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-744816000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4036000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-42030000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-42030000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-42030000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,,2017-06-30,2017-08-09 06:04:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,189999000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45577000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,24990000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19103000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16105000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6510000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,112285000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,702000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,70108000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,464000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,188000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,70760000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,,totalassets,Total Assets,=,debit,usd,183747000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10933000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,44061000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1238000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,56232000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25367000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6538000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,157977000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,189882000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,246114000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,710623000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-765645000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7345000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-62367000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-62367000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-62367000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,,2017-09-30,2017-11-13 19:56:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,183747000.0
